Living with HER2+ Secondary Breast Cancer: Diane Lavin’s Experience

In our third blog with Make2ndsCount, we’ll be looking in depth at current and future treatments for HER2 secondary breast cancer patients.

blogs

HER2 Secondary Breast Cancer: All of the treatments explained

In our third blog with Make2ndsCount, we’ll be looking in depth at current and future treatments for HER2 secondary breast cancer patients.

blogs
Birds flying signifying the hope Enhertu has brought to secondary breast cancer patients

Enhertu for Secondary Breast Cancer: Science and Stories

Trastuzumab deruxtecan (Enhertu®) is used to treat certain secondary breast cancers. This blog delves into the science while looking at the real experiences of patient’s on this drug.

blogs
An image of flowers and the sky to signify hope for HER2-low breast cancer patients

What is HER2-low Breast Cancer?

HER2-low is a new way to characterise breast cancer. In short, many previously considered HER2-negative breast cancer patients can now be considered HER2-low. This provides a new treatment target for many secondary (metastatic, advanced) breast cancers. 

blogs

Tumour gene tests: What are they and why should you know about them?

Genomic tests have changed how cancer is treated. In this blog we explain the objective and the different types of genomic tests available.

blogs
Untangling drug terminology

Untangling monoclonal antibodies – Trastuzumab, Pertuzumab, Atezolizumab

We know that drug names can be confusing. That’s why we’re untangling drug terminology. Starting with the monoclonal antibodies (AKA the mabs).

blogs
Clinical trials - a doctor holding a new drig

Clinical Trials for Breast Cancer: Our A to Z Guide

Want to better understand what clinical trials are and what they mean for you? Here is OWise’s extensive guide to all things clinical trials.

blogs
Woman holding magnifying glass

It’s All About HER2-Positive Breast Cancer

If you have HER2-positive breast cancer, this is the blog for you! Find out exactly what HER2 is and how it may affect your treatment plan.

blogs
Scientific image of pipette with pink liquid being placed into plate

HER2 and Herceptin®: A Look at the History

The discovery of the HER2 gene led to the development of Herceptin®: a targeted therapy that is widely used today for HER2+ breast cancer patients.

blogs

What are monoclonal antibodies?

There is a lot of terminology that comes with a breast cancer diagnosis. Explore how monoclonal antibodies such as Herceptin® work and how to recognise them!

blogs